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Quadrant Field Pupillometry 
Detects Melanopsin Dysfunction 
in Glaucoma Suspects and Early 
Glaucoma
Prakash Adhikari1,2, Andrew J. Zele1,2, Ravi Thomas3,4 & Beatrix Feigl1,3,5
It is difficult to detect visual function deficits in patients at risk for glaucoma (glaucoma suspects) and 
at early disease stages with conventional ophthalmic tests such as perimetry. To this end, we introduce 
a novel quadrant field measure of the melanopsin retinal ganglion cell mediated pupil light response 
corresponding with typical glaucomatous arcuate visual field defects. The melanopsin-mediated post-
illumination pupil response (PIPR) was measured in 46 patients with different stages of glaucoma 
including glaucoma suspects and compared to a healthy group of 21 participants with no disease. 
We demonstrate that the superonasal quadrant PIPR differentiated glaucoma suspects and early 
glaucoma patients from controls with fair (AUC = 0.74) and excellent (AUC = 0.94) diagnostic accuracy, 
respectively. The superonasal PIPR provides a linear functional correlate of structural retinal nerve 
fibre thinning in glaucoma suspects and early glaucoma patients. This first report that quadrant PIPR 
stimulation detects melanopsin dysfunction in patients with early glaucoma and at pre-perimetric 
stages may have future implications in treatment decisions of glaucoma suspects.
Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness1. It causes a progressive 
and chronic loss of Retinal Ganglion Cells (RGCs) and their axons, leading to optic nerve atrophy2. Standard 
Automated Perimetry (SAP) is the principle measure of glaucomatous visual deficits and the visual field loss cor-
relates with regional RGC loss3–5, but significant RGC damage occurs before a visual defect is detected3,6,7. Retinal 
Nerve Fibre Layer (RNFL) imaging can potentially detect early structural changes in glaucoma8 that correspond 
with sectoral visual field deficits7,9. Together, the visual fields and RNFL imaging provide evidence for a preferen-
tial vulnerability of the inferior RNFL in glaucoma8,10,11. While the detection of early glaucomatous damage using 
emerging technologies shows promising results8,11–19, the detection of pre-perimetric glaucomatous deficits still 
remains a challenge.
The discovery of melanopsin20–22 expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) adds 
a new dimension to the detection and monitoring of the progression of retinal and optic nerve disorders, includ-
ing glaucoma through pupillometry23–36 (see Feigl & Zele, 2014 for review32). Five different ipRGC subtypes in 
transgenic mice and two ipRGC subtypes in primates have been identified that differ in morphology and project 
to different brain areas32,37. The main subtype of interest for this study is the M1 ipRGC which pre-dominantly 
innervates the olivary pretectal nucleus shell for pupil control38. These inner retinal photoreceptors entirely drive 
the post-illumination pupil response (PIPR)21,28,39. This sustained pupil constriction after light offset matches 
the spectral sensitivity of the melanopsin pigment (≥ 1.7 s after light offset) such that it can be used as a direct 
biomarker of ipRGC function21,28,39,40. The pupil light reflex (PLR) during light stimulation is mediated via both 
outer retinal and inner retinal photoreception with the relative photoreceptor contributions depending on the 
stimulus paradigm41–43.
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Melanopsin function in glaucoma has been assessed by measuring the PLR during light stimulation27,35,44 
and the PIPR after light offset23–26,36,45. Focal retinal stimulation pupillometry23,28,35,44,46–50 is useful for detecting 
localised damage in ocular diseases including glaucoma. In late, but not early glaucoma, there is a relative afferent 
pupillary defect in the quadrant field44,48 and localised changes in the PLR are detectable with multifocal stimuli35. 
The melanopsin-mediated PIPR is affected in the central visual field in late glaucoma23–26,36,45, but not in early 
glaucoma23. A recent study observed a normal PIPR in ocular hypertension45. The PIPR has not been measured 
in glaucoma suspects. Based on typical glaucomatous arcuate deficits51,52 and RNFL defects8,11, and evidence that 
regional visual field deficits can be mapped to sectoral optic disc abnormalities in glaucoma7,9,53,54, we introduce 
a quadrant field stimulation paradigm using optimised pupillometry protocols39 in order to differentiate mel-
anopsin function in glaucoma suspects and manifest glaucoma at different severity stages from healthy eyes by 
measuring the PLR and PIPR. Based on evidence that melanopsin dysfunction is related to sleep disorders in late 
glaucoma patients26 and reports that melanopsin gene (OPN4) variants modulate the pupil response and sleep 
behaviour55–58, a secondary aim was to investigate if the established OPN4 variants could affect the PIPR or sleep, 
independent of the different stages of glaucoma.
Methods
Participants. Patients were recruited from the private practice of one glaucoma specialist who determined 
the stage of glaucoma (suspect, early, moderate, advanced). The diagnosis of glaucoma suspect and glaucoma 
followed the American Academy of Ophthalmology Preferred Practice Pattern Guidelines2,59. The diagnosis of 
POAG was based on the presence of a combination of glaucomatous optic disc (diffuse or focal narrowing of 
the rim, rim notching defined as one clock hour of rim loss at the inferior or superior quadrants, disc haemor-
rhage, rim to disc ratio < 0.160, diffuse or focal nerve fibre layer damage, cup disc ratio > 0.7, inter-eye asymmetry 
of cup disc ratio > 0.2) with confirmed, correlating, and repeatable visual field defects on standard automated 
perimetry (SAP). Primary open-angle glaucoma was classified as early (mean deviation; MD < − 6 dB), moderate 
(− 6 dB ≤ MD < − 12 dB), and advanced (MD > − 12 dB) on the basis of a visual field mean deviation according 
to the Hodapp, Parrish, and Anderson classification61. Glaucoma suspects were defined on the basis of the optic 
nerve changes described above, but no visual field defects that correlated with the clinical examination of the 
optic disc59.
We recruited 67 participants in the study: 34 patients with early (n = 22), moderate (n = 6), and advanced 
(n = 6) POAG (age range = 50–90 years), 12 glaucoma suspects (age range = 50–77 years), and 21 healthy con-
trols (age range = 42–74 years) (see ‘Results’ for participant characteristics). As moderate and advanced glaucoma 
patients are known to have a reduced PIPR23 (and pupillometry is not needed for further differentiation), they 
were analysed together as the “late” glaucoma group (n = 12). Based on a previous study23, a sample size calcu-
lation determined that 12 participants in each sub-group are required to achieve 90% power (effect size = 1.29) 
(G*Power 3.1) for detecting a significant mean difference of 5.8% in the PIPR amplitude between glaucoma sus-
pects/patients and healthy controls.
All glaucoma suspects and patients underwent a complete eye examination including visual acuity, intraocular 
pressure (IOP, Goldmann tonometer AT 900, Haag-Streit AG, Koeniz, Switzerland), colour vision (Ishihara), slit 
lamp biomicroscopy, ophthalmoscopy, visual field (Humphrey 30-2, Humphrey Field Analyzer, HFA, Carl Zeiss 
Meditec, Inc. Dublin, CA), and optical coherence tomography (OCT) nerve fibre layer and disc map (Cirrus-HD 
OCT, Carl Zeiss Meditec, Inc. Dublin, CA). All glaucoma suspects and patients were using IOP lowering topi-
cal medications; there is a known miotic effect from brimonidine62–65 and travoprost66, whereas bimatoprost67, 
brinzolamide68,69, latanoprost70, and timolol70–72 have minimal (≤ 0.2 mm) or no miotic effects on the pupil. The 
potential effect of any drug mediated miosis on the pupil light reflex amplitude was compensated for by normal-
ising the amplitude to the baseline pupil diameter73,74. Nineteen patients with manifest glaucoma had undergone 
some kind of surgical intervention for glaucoma (trabeculectomy (n = 2), selective laser trabeculoplasty (n = 7), 
and laser peripheral iridotomy (n = 10)); the iris dynamics (PIPR redilation velocity) used for determining the 
PIPR amplitude did not differ between patients with and without surgery. There is evidence that the PIPR ampli-
tude increases after cataract surgery due to an increased retinal irradiance that enhances ipRGC photoreception75. 
A small proportion of our participants in each group (one control, two suspects, five early, and four late glaucoma 
patients) had cataract surgery with intraocular lens implants (see ‘Results’). They had normal pupillary margins 
and no sphincter tear and the PLR and PIPR amplitudes were similar to the fellow participants with natural lenses 
indicating cataract surgery had limited or no effect on the pupil results. Participants with ocular pathology other 
than glaucoma were excluded, including any kind of retinopathy or optic neuropathy as well as corneal opacities, 
lenticular opacification > grade 2 (Lens Opacities Classification System, LOCS III)76, and a history of uveitis.
The healthy controls were recruited from a university cohort and age-matched with the glaucoma suspects 
because the primary aim of the study was to detect early melanopsin dysfunction in suspects. They had no ocular 
or systemic pathology, no corneal opacity, lenticular opacification < grade 2 (LOCS III), and no history of uvei-
tis. Because the PIPR is robust to healthy ageing74,77, exact age matching is not mandatory but was performed to 
enable comparisons with other studies. Absence of ocular pathology was confirmed with a complete eye exam-
ination as detailed above and including contrast-sensitivity (Pelli-Robson Chart) and colour vision (Lanthony 
Desaturated D-15 test).
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI)78. DNA genotyping was performed 
to detect the OPN4 gene single nucleotide polymorphisms (SNPs) P10L and I394T; genotyping followed estab-
lished procedures and as previously performed in our studies79,80.
All experimental protocols were approved by the Queensland University of Technology (QUT) Human 
Research Ethics Committee (approval no.: 1400000793) and conducted in accordance with their guidelines. 
The research followed the tenets of the Declaration of Helsinki and informed consent was obtained from all 
participants.
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Pupillometry. We designed two new pupillometric stimulus paradigms based on the location of Retinal 
Nerve Fibre Layer (RNFL) defects in glaucoma8,11,51,52: A superonasal field (SNF, 18.4°, retinal image altitude: 
8 mm) and an inferonasal field (INF, 18.4°, retinal image altitude: 8 mm) stimulus, both sparing the central 5° (ret-
inal diameter: 2 mm) to avoid the stimulation of the foveal zone devoid of ipRGCs based on their anatomical dis-
tributions81,82 (Fig. 1A). A conventional full field stimulus (41° in diameter, retinal image diameter: 17.9 mm) was 
also applied. The PLR was measured in Maxwellian view with a custom-designed pupillometer (see Feigl et al.23 
and Adhikari et al.39 for details) using 1 s light pulses based on our previous research where 1 s pulses produced 
larger PIPRs than longer (10 s and 30 s) stimulus durations39. The stimuli included narrow-band blue lights (short 
wavelength, λ max = 464 nm, 20 nm band-width at half maximum, corneal irradiance: 15.5 log quanta.cm−2 s−1, 
luminance: 2.9 log cd.m−2) with high melanopsin excitation (8601.7 α -opic lux83) and red lights (long wavelength, 
λ max = 658 nm, 22 nm band-width at half maximum, corneal irradiance: 15.5 log quanta.cm−2 s−1, luminance: 3.1 
log cd.m−2) with low melanopsin excitation (0.5 α -opic lux); the presentation order was alternated to account for 
the effect of a suggested melanopsin bistability84. In addition to the 1 s pulse, the SNF stimulus was also presented 
as a sinusoidal stimulus (0.5 Hz, 6 cycles, 11.9 s duration) to evaluate the interaction between inner and outer 
retinal inputs to the phasic pupil response32,34,85 (Fig. 1B).
In all participants, the left pupil was dilated (1% Tropicamide, Minims, Chauvin Pharmaceuticals Ltd., 
Romford, UK) to maintain a constant retinal irradiance and was stimulated to measure the consensual PLR of the 
right eye. All measurements were preceded by 10 minutes dark adaptation (< 1 lux) to eliminate the effect of prior 
light exposure on the pupil light response39. The baseline pupil diameter was measured in the dark for 10 s before 
stimulus onset and the PIPR was measured for 40 s after stimulus offset. Measurements were repeated twice; 
the intra-individual coefficients of variation (CV) of the peak pupil constriction and PIPR amplitudes with blue 
full field stimuli were 0.03 ± 0.03 and 0.10 ± 0.11 (mean ± SD), respectively, which are below the recommended 
acceptance limit for CV86. Pupillometry was performed between 10 AM and 5 PM to minimise the effects of cir-
cadian variation of the PIPR amplitude46,87.
Quantification of the PLR and PIPR. The PLR during light stimulation was quantified using the transient 
PLR, peak pupil constriction amplitude, time to peak constriction, and phase amplitude percentage (PAP) metrics 
defined in Table 1. The PIPR amplitude was quantified with the 6 s and plateau PIPR metrics based on previous 
findings that determined optimum PIPR metrics (Adhikari et al.39). Since both the plateau and 6 s PIPR metrics 
showed similar outcomes, only the 6 s PIPR is presented and subsequently reported as the PIPR amplitude.
Statistical analysis. GraphPad Prism (GraphPad Software, Inc., CA, USA) was used for statistical analysis. 
Comparisons of the PLR and PIPR metrics were performed between the four groups: Healthy controls, glaucoma 
Figure 1. Characteristics of the pupillometry stimulus fields represented in the visual space of the left (test) 
eye (Panel A). Schematic of the pupillometry protocol (Panel B). The pulse and sinusoidal stimulus protocols 
indicated by arrows were common for blue and red stimuli. Blue stimuli (blue rectangles) and red stimuli (red 
rectangles) were alternated and measurements were repeated twice. The double slashes indicate a two-minute 
interval between the tests to allow the pupil return to the baseline size39. PRE, pre-stimulus; PIPR, post-
illumination pupil response; SNF, superonasal field; INF, inferonasal field.
www.nature.com/scientificreports/
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suspects, early glaucoma, and late glaucoma. The data frequency distributions were evaluated with the D’Agostino 
and Pearson omnibus normality test. Normal data were analysed with one-way ANOVA (Tukey’s multiple com-
parisons) and non-normal data were analysed with the Kruskal-Wallis test (Dunn’s multiple comparisons) to 
compare the PLR and PIPR between the four (suspect, early, late, and control) study groups (95% confidence 
interval, p < 0.05, Geisser-Greenhouse correction). The pupil metrics are presented in Box-and-Whisker plots 
showing the median, 25% and 75% quartiles, and range of the data. The relationship between the PIPR amplitude 
and mean RNFL thickness or visual field MD was evaluated with linear or non-linear regression, respectively 
and the statistical significance of linear regression was determined on the basis of whether or not the slope of the 
best-fitting regression line was significantly different from zero using F-test (95% confidence interval, p < 0.05). 
Receiver operating characteristic (ROC) analysis was performed to determine the diagnostic accuracy of the 
PIPR to differentiate glaucoma suspects and established glaucoma patients from healthy control participants.
Results
The clinical characteristics of the 67 participants given in Table 2 indicate that RNFL thickness and visual field 
sensitivity were significantly reduced in early and late glaucoma patients compared to controls. The results of 
the statistical analyses are included within the Figures. The averaged pupil response traces to the blue stimulus 
with high melanopsin excitation for the controls, glaucoma suspects, early glaucoma and late glaucoma partici-
pants (Fig. 2) show that the mean peak pupil constriction and the PIPR amplitudes differed between the groups; 
detailed results follow. The transient PLR (Fig. 3) to the 1 s red stimuli was significantly reduced in late glaucoma 
for all field sizes (full field: F3,57 = 3.48, p = 0.02; SNF: F3,60 = 4.02, p = 0.01; INF: F3,58 = 5.77, p = 0.002) when 
compared to healthy controls, and with the SNF sinusoidal stimulus, but not for the blue stimulus. The peak pupil 
constriction amplitude (Fig. 4) was significantly reduced in late glaucoma compared to controls with blue (full 
field: H = 19.09, p = 0.0003; SNF: H = 15.29, p = 0.02; INF: H = 16.63, p = 0.0008) and red (full field: H = 19.16, 
p = 0.0003; SNF: F3,61 = 8.83, p < 0.0001; INF: H = 18.03, p = 0.0004) stimuli for all stimulus fields. With the blue 
quadrant stimuli, the peak constriction was also significantly reduced in early glaucoma compared to controls. 
The time to peak pupil constriction (Fig. 5) was significantly shorter in late glaucoma compared to controls with 
the blue full field stimulus (H = 10.46, p = 0.02). The phase amplitude percentage (PAP) derived from the SNF 
sinusoidal stimulation was not significantly different between the four participant groups (Fig. 6).
The melanopsin-controlled PIPR was significantly reduced in early and late glaucoma patients compared to 
controls with the quadrant (SNF: F3,62 = 25.37, p < 0.0001; INF: H = 42.05, p < 0.0001) and full field stimulation 
(H = 37.21, p < 0.0001) (Fig. 7). Importantly, glaucoma suspects exhibited significantly reduced PIPR amplitudes 
with SNF stimuli, indicative of the effectiveness of the quadrant field paradigm to detect melanopsin dysfunc-
tion. Given that the superonasal field PIPR amplitude differentiated melanopsin dysfunction in glaucoma sus-
pects from controls, we further compared the superonasal field results with SAP visual fields and OCT (RNFL 
Metrics Definitions and Units
Baseline pupil diameter Average over 10 s pre-stimulus period (mm, %)
PLR Metrics
Transient PLR Peak % constriction from 180–500 ms after light onset31,43
Peak pupil constriction Minimum pupil size during light stimulation (% baseline)
Time to peak constriction Time to peak constriction amplitude, s39
Phase amplitude percentage (PAP) % difference in the peak-to-trough amplitude between 465 nm and 658 nm sine wave stimuli32,34
PIPR Metrics
6 s PIPR amplitude Pupil size at 6 s after light offset (% baseline)23,29,46
Plateau PIPR amplitude Plateau of exponential model fit to the post-stimulus pupil data (% baseline)23
Table 1.  Definitions for the PLR metrics during light stimulation and PIPR metrics after light offset 
(following Adhikari et al.39).
Characteristics Control (n = 21) Suspect (n = 12) Early (n  = 22)
Late (Moderate + Advanced) 
(n = 12) p-value
Age (yrs); Gender 58.2 ± 9.2; 3 F, 18 M 61.7 ± 9.7; 5 F, 7 M 66.6 ± 10.6* 11 F, 11 M 69.0 ± 9.1* 6 F, 6 M 0.008
Visual Acuity (logMAR) 0.01 ± 0.02 0.04 ± 0.08 0.07 ± 0.10* 0.07 ± 0.09* 0.03
Contrast Sensitivity 1.67 ± 0.10 1.63 ± 0.10 1.63 ± 0.14 1.54 ± 0.15 0.14
IOL 1 Y, 20 N 2 Y, 10 N 5 Y, 17 N 4 Y, 8 N —
RNFL Thickness (μ m) 86.8 ± 13.7 74.7 ± 10.1 71.9 ± 11.3* 63.5 ± 10.6* 0.0008
VF MD (dB) − 0.61 ± 1.57 − 2.20 ± 1.13 − 2.71 ± 0.98* − 11.58 ± 3.51* < 0.0001
Table 2.  Clinical characteristics (mean ± SD) of controls, glaucoma suspects, and glaucoma patients. F, 
female; M, male; IOL, intraocular lens; Y, yes; N, no; RNFL, retinal nerve fibre layer; VF MD, visual field mean 
deviation. *Statistically significant difference to controls.
www.nature.com/scientificreports/
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thickness) used in conventional glaucoma screening and monitoring. A non-linear model7 best described the 
relationships between visual field MD and mean RNFL thickness, and with PIPR amplitude (Fig. 8A,B). The supe-
ronasal and inferonasal visual field MD also showed non-linear relationships with the corresponding superonasal 
and inferonasal field PIPR amplitude (Fig. 8D,E). Notably, a linear model best described the positive association 
between mean RNFL thickness and the PIPR amplitude (Fig. 8C)88. There was no association between IOP and 
the PIPR.
The ROC analysis demonstrated that the superonasal PIPR has a fair diagnostic accuracy89 (AUC = 0.74, 
p = 0.03) to discriminate melanopsin dysfunction in glaucoma suspects from healthy eyes and excellent diagnos-
tic accuracy to discriminate early glaucoma (AUC = 0.94, p < 0.0001) and late glaucoma (AUC = 0.97, p < 0.0001) 
from healthy eyes (Fig. 9). Based on the ROC analysis, PIPR cut-off values were chosen to provide sensitivities 
> 90% to detect melanopsin dysfunction in glaucoma suspects and patients compared to controls and the cor-
responding positive and negative likelihood ratios (LR’s) were calculated. At the selected PIPR cut-off values for 
glaucoma suspects and patients (Table 3), the positive LR’s signify ability to cause small to moderate increases 
in the clinical probability of glaucoma whereas the corresponding negative LR’s signify ability to cause moderate 
to large decreases in the clinical probability of glaucoma89,90. For glaucoma suspects, a 25.6% PIPR cut-off value 
had a positive LR of 2.0 and a negative LR of 0.15; for early glaucoma, a 17.0% PIPR had a positive LR of 3.8 and a 
negative LR of 0.06. In late glaucoma, a 13.8% PIPR had a positive LR of 9.2 and a negative LR of 0.09. The PIPR 
values below the cut-off generally resulted in decreased sensitivities and increased specificities and likelihood 
ratios whereas the PIPR values above the cut-off resulted in increased sensitivities and decreased specificities and 
likelihood ratios as might be expected.
All participants had normal sleep patterns. However, the TT risk allele of the OPN4 SNP P10L that has been 
associated with sleep disturbances was present in only one participant (an early glaucoma patient). The peak pupil 
constriction amplitude and the PIPR amplitude did not vary significantly within the OPN4 SNP I394T alleles that 
have been previously linked with lower PIPR amplitudes (Fig. 10).
Discussion
Our results show that selective superonasal quadrant field stimulation can be used to detect melanopsin express-
ing intrinsically photosensitive Retinal Ganglion Cell (ipRGC) dysfunction in glaucoma suspects in the absence 
of perimetric deficits (Fig. 7). Importantly, this new PIPR quadrant stimulation paradigm can differentiate mel-
anopsin dysfunction in glaucoma suspects and early glaucoma from healthy controls with fair and excellent diag-
nostic accuracy, respectively (Fig. 9). In contrast, full field pupillometry stimulation is sensitive only to changes 
in the melanopsin-mediated PIPR in more advanced stages of glaucoma23,24. The negative likelihood ratios in 
glaucoma suspects and early glaucoma were estimated using cut-off values to provide sensitivities > 90% and 
Figure 2. Averaged pupil traces for controls (n = 21), glaucoma suspects (n = 12), early glaucoma (n = 22) 
and late glaucoma patients (n = 12) in response to a 1 s, 464 nm, 15.5 log quanta.cm−2 s−1 light pulse 
(indicated by the blue bar on the abscissa at 0 s) presented in the superonasal quadrant field. The shaded 
areas for the controls and thinner lines for the glaucoma suspects, early glaucoma and late glaucoma patients 
indicate 95% confidence limits (CL) of the mean (μ ). The vertical line denotes the PIPR amplitude.
PIPR Cut 
Off (%)
Sensitivity Specificity Positive 
Likelihood Ratio
Negative 
Likelihood Ratio% 95% CL* % 95% CL
Suspect 25.6 91.7 61.5 to 99.8 55.0 31.5 to 76.9 2.04 0.15
Early 17.0 95.5 77.2 to 99.9 75.0 50.9 to 91.3 3.82 0.06
Late 13.8 91.7 61.5 to 99.8 90.0 68.3 to 98.8 9.17 0.09
Table 3.  Sensitivity and specificity of the superonasal post-illumination pupil response (PIPR) in glaucoma. 
*CL, confidence limits.
www.nature.com/scientificreports/
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indicate that the PIPR quadrant test may have potential in the important clinical decision to rule out disease and 
to estimate the required frequency of follow up for the individual patient89.
Our finding of reduced PIPR amplitudes with selective superonasal field stimulation in glaucoma suspects 
and early glaucoma is consistent with rodent models of ipRGC abnormalities in the early stages of experimental 
glaucoma91–96 and with the preferential vulnerability of the inferior retina in glaucoma in humans8,10,11. Reduced 
blood flow resulting from high IOP or reduced arterial pressure can lead to ischaemic nerve fibre damage in 
Figure 3. The transient pupil light reflex (PLR) plotted as a function of percentage (%) baseline pupil 
diameter with different stimulus field conditions (full field, SNF, INF) for controls (n = 21), glaucoma 
suspects (n = 12), early glaucoma patients (n = 22), and late glaucoma patients (n = 12). Left panels show the 
data for the blue stimulus lights; right panels show the data for the red stimulus lights. A significant reduction 
is demonstrated in response to red stimuli in late glaucoma for all field sizes. Asterisks indicate statistically 
significant difference from controls (*p < 0.05, **p < 0.01, ***p < 0.001). SNF, superonasal field; INF, inferonasal 
field.
www.nature.com/scientificreports/
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glaucoma97 which is most pronounced in the inferior retina10. The inferotemporal RNFL loss is most frequently 
detected in the OCT in glaucoma suspects and early glaucoma patients and has the highest diagnostic accuracy 
for early glaucoma8,11. Additionally, the linear relationship between a lower PIPR amplitude and a reduced mean 
RNFL thickness in our study sample (Fig. 8C) is in agreement with recent studies27,88. The linear relationship 
between the PIPR and RNFL thickness may therefore have value in the prediction of functional deficits based on 
structural defects.
Advanced glaucoma patients with deficits in the central 7° on microperimetry that are not evident on Standard 
Automated Perimetry (SAP), have greater PIPR deficits compared to early glaucoma patients23. This evidence of 
ipRGC dysfunction in the central retina23 and the association between a lower PIPR and greater visual field 
defects in advanced glaucoma24 highlight the importance of developing and refining selective field stimulation 
pupillometry.
The reduced transient PLR to red stimuli in late glaucoma (Fig. 3) indicates cone dysfunction43 consistent with 
evidence of a decrease in cone density98 as demonstrated by a reduced photopic a-wave amplitude in the elect-
roretinogram in glaucoma patients99. Though rod loss and dysfunction have been reported in glaucoma100,101, our 
pupillometry protocol was optimised to measure ipRGC function rather than rod function. The stimulus protocol 
may reveal rod deficits in glaucoma when tested at scotopic light levels28,43.
The peak pupil constriction amplitude (Fig. 4) was reduced in late glaucoma in agreement with the litera-
ture27,44,102,103. With high irradiance short wavelength lights, the peak pupil constriction amplitude quantifies 
Figure 4. The peak pupil constriction amplitude plotted as a function of percentage (%) baseline pupil 
diameter with different stimulus field conditions (full field, SNF, INF) for controls (n = 21), glaucoma 
suspects (n = 12), early glaucoma patients (n = 22), and late glaucoma patients (n = 12). Left panels show the 
data for the blue stimulus lights; right panels show the data for the red stimulus lights. A significant reduction in 
amplitude is evident in response to red and blue lights in late glaucoma for all field sizes and for blue lights also 
in early glaucoma for both quadrant stimuli. Asterisks indicate statistically significant difference from controls 
(*p < 0.05, **p < 0.01, ***p < 0.001). SNF, superonasal field; INF, inferonasal field.
www.nature.com/scientificreports/
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Figure 5. The time to peak pupil constriction amplitude in seconds with different stimulus field conditions 
(full field, SNF, INF) for controls (n = 21), glaucoma suspects (n = 12), early glaucoma patients (n = 22), 
and late glaucoma patients (n = 12). Left panels show the data for the blue stimulus lights; right panels show 
the data for the red stimulus lights. A significantly shorter time to the peak constriction is demonstrated in 
response to blue lights in late glaucoma for the full field stimulus only. Asterisks indicate statistically significant 
difference from controls (*p < 0.05). SNF, superonasal field; INF, inferonasal field.
Figure 6. The phase amplitude percentage (PAP) with sinusoidal superonasal field (SNF) stimuli shows 
no significant difference between controls (n = 21), glaucoma suspects (n = 12), early glaucoma patients 
(n = 22), and late glaucoma patients (n = 12). 
www.nature.com/scientificreports/
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both outer and inner retinal contributions to the PLR41 and our finding indicates that these contributions are 
compromised in late glaucoma. In this study, a deficit in the peak constriction amplitude became evident in 
early glaucoma only with the quadrant field blue stimulus, and not with the full field, possibly due to the signals 
from the intact outer retina photoreceptors masking the presence of localised ipRGC dysfunction. The time to 
peak constriction with the full field stimulus (Fig. 5) was shorter in late glaucoma compared to healthy eyes, 
likely due to ipRGC dysfunction. The ipRGC inputs to the pupil control pathway has larger spatial summation 
areas49,50 compared to the spatial summation areas of image forming vision104 and therefore with high irradiance 
short wavelength lights, ipRGCs produce larger constriction amplitudes and delay the time to peak constriction39 
compared to rods and cones105. Based on this evidence, we infer that the shorter time to peak constriction in late 
glaucoma with full field short wavelength stimuli is likely due to ipRGC dysfunction. We also determined that 
the inner and outer retinal interactions quantified with the phase amplitude percentage (PAP) are not affected in 
glaucoma (Fig. 6).
Our participants did not exhibit sleep disorders as assessed with the PSQI; it is possible that sleep disorders 
may have been detected with polysomnography as previously reported26 but this was outside scope of our study. 
While the OPN4 SNP P10L TT genotype has been demonstrated to be associated with poorer sleep quality, there 
was only one patient with the TT risk allele in our cohort. We therefore infer that our results of normal sleep 
behaviour in glaucoma patients may in some part reflect the low frequency of the risk allele in our participants 
and the smaller sample of late glaucoma patients. Notably, the I394T genotype did not affect any of the pupil met-
rics (Fig. 10), suggesting that this OPN4 gene variant was not a contributor to the lower PIPR and PLR responses 
in the glaucoma patients.
Increased PIPR amplitudes have been found to occur in older people due to lens scattering106, however we 
limited lens scattering by excluding patients with lens opacification > 2 (LOCS III). Based on literature evidence, 
the PIPR is robust to healthy ageing in humans74,77 and ipRGC density is independent of age in rodent models107, 
suggesting that exact age matching is not mandatory. However, if lens scatter had affected the PIPR, higher, and 
not lower PIPR amplitudes as found in this study, might have been observed.
The primary aim of this study was to determine if the quadrant pupillometry protocol can detect a mean 
difference in melanopsin cell function in glaucoma suspects, early glaucoma patients, and controls; the sample 
size was therefore optimised to examine this aim rather than to determine the diagnostic accuracy and as such 
the reported sensitivity and specificity of the PIPR have wide confidence limits (Table 3). The ROC AUC of 74% 
in glaucoma suspects is not optimal; studies with larger samples are necessary to refine our estimate of the diag-
nostic accuracy of the quadrant pupillometry protocol and a longitudinal study is needed to determine if suspects 
Figure 7. The post-illumination pupil response (PIPR) amplitude plotted as a function of percentage (%) 
baseline pupil diameter with different stimulus field conditions (full field, SNF, INF) for controls (n = 21), 
glaucoma suspects (n = 12), early glaucoma patients (n = 22), and late glaucoma patients (n = 12) shows 
deficits for all field sizes in early and late glaucoma. Glaucoma suspects exhibit superonasal deficits and differ 
significantly from early glaucoma patients. Asterisks indicate statistically significant difference from controls 
(*p < 0.05, ***p < 0.001, ****p < 0.0001). SNF, superonasal field; INF, inferonasal field.
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proceed to manifest glaucoma. Nevertheless, the reported point estimates and upper end of the confidence limits 
suggest that the test may have good potential as a clinical tool in the detection of pre-perimetric glaucomatous 
damage and the identification of early glaucoma.
In conclusion, we show that the superonasal field melanopsin PIPR measurement can detect inner retinal mel-
anopsin dysfunction in glaucoma suspects in line with the preferential vulnerability of the inferior nerve fibres in 
glaucoma. Quadrant melanopsin pupillometry provides a linear functional correlate of structural retinal nerve 
fibre thinning in glaucoma suspects and early glaucoma patients, with potentially excellent diagnostic accuracy 
Figure 8. Scatterplots of mean retinal nerve fibre layer (RNFL) thickness versus visual field mean deviation 
(MD) (A), the post-illumination pupil response (PIPR) amplitude versus visual field MD (B), the PIPR versus 
mean RNFL thickness (C), the superonasal field (SNF) PIPR versus superonasal visual field MD (D), and the 
inferonasal field (INF) PIPR versus inferonasal visual field MD (E) in controls (red circles), glaucoma suspects 
(green squares), early glaucoma patients (blue triangles), and late glaucoma patients (purple inverted triangles). 
Visual field MD has a non-linear relationship with RNFL thickness and the PIPR; and lower PIPRs are linearly 
related to reduced RNFL thickness. Solid lines are the best fitting models.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:33373 | DOI: 10.1038/srep33373
in the latter. It may have future applications as a non-invasive and objective clinical tool for monitoring functional 
changes in melanopsin expressing ipRGCs during disease progression, and detecting functional pupillometric 
changes in suspects prior to the onset of perimetric deficits.
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